Overexpression of KRT6B was associated with worse DFS in younger patients with HER2-enriched breast cancer only (p = 0.01, HR 4.1); an inverse relationship was seen in older patients in this group (p = 0.14, HR 0.65) (Figure 4). Here, ERBB2 is linked to breast carcinoma.